Cargando…
A case of thoracic SMARCA4‐Deficient undifferentiated tumor successfully treated with combination Ipilimumab–Nivolumab
Thoracic SMARCA4‐deficient undifferentiated tumors are rare, with poor prognosis. A 73‐year‐old man presented to our hospital with dyspnea. Computed tomography‐guided biopsy revealed a SMARCA4‐deficient undifferentiated tumor. The patient was treated with combination ipilimumab‐nivolumab. The tumor...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748223/ https://www.ncbi.nlm.nih.gov/pubmed/36523385 http://dx.doi.org/10.1002/ccr3.6745 |